Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion

Por Fleming, Gini F, Schumm, Philip, Friberg, Greg, Ratain, Mark J, Njiaju, Uchenna O, Schilsky, Richard L
Publicado no BMC Cancer (2015)

A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours

Por Hong, David S., Kurzrock, Razelle, Mulay, Marilyn, Rasmussen, Erik, Wu, Benjamin M., Bass, Michael B., Zhong, Zhandong D., Friberg, Greg, Rosen, Lee S.
Publicado no Oncotarget (2014)

AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues

Por Juan, Gloria, Bush, Tammy L, Ma, Connie, Manoukian, Raffi, Chung, Grace, Hawkins, Jennifer M, Zoog, Stephen, Kendall, Richard, Radinsky, Robert, Loberg, Robert, Friberg, Greg, Payton, Marc
Publicado no J Transl Med (2014)